farmaco semaglutide FDA issues warning about some compounded versions of for diabetes, weight loss Semaglutide 3 Semaglutide for weight loss |

Okemah JA-O, Peng J, Quiones M

Theres a lot of controversy amongst pediatricians, pediatric endocrinologists and physicians in general about how we should be treating pediatric obesity, says Oshman

Common Side Effects Nausea and vomiting: The most frequently reported effects, especially at the beginning of treatment

Oral Wegovy: Semaglutide Pill FDA-approved in December 2025, the Wegovy pill offers a daily oral option for weight management, offering the same effective GLP-1 science found in injectable Wegovy

Third, no cookie-cutter approaches here

Important: Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and is not recommended during pregnancy, especially when used for weight management